Gladstone NOW: The Campaign Join Us on the Journey✕
Isha Jain, PhD, and her team developed a drug that mimics the effects of breathing low oxygen, which could be life-saving for people with mitochondrial diseases who rarely survive past childhood. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the drug extended lifespan three-fold and reversed symptoms, even when given during late stages of disease. The new drug shows the promise of gas-based therapies for mitochondrial diseases and other common brain and cardiovascular conditions for which low oxygen has been shown to be beneficial.
In this video, Jain and research associate Skyler Blume explain the science behind their discovery and the impact it could have for mitochondrial diseases. Read more about this discovery.
Featured Experts
Gladstone NOW: The Campaign
Join Us On The Journey
New Tool Reveals the Secrets of HIV-Infected Cells
Article
March 3, 2026
New Tool Reveals the Secrets of HIV-Infected Cells
Developed by Gladstone scientists, HIV-seq could uncover new opportunities for treating HIV.
News Release Research (Publication) HIV/AIDS Infectious Disease Roan LabVitamin B3 Therapy Offers Hope for Fatal Childhood Disease
Article
February 25, 2026
Vitamin B3 Therapy Offers Hope for Fatal Childhood Disease
A new framework that matches vitamins with genetic diseases helped uncover that high-dose vitamin B3 can dramatically extend survival in mice with NAXD deficiency.
News Release Research (Publication) Rare Diseases Jain LabRed Blood Cells Soak Up Sugar at High Altitude, Protecting Against Diabetes
Article
February 19, 2026
Red Blood Cells Soak Up Sugar at High Altitude, Protecting Against Diabetes
New study shows red blood cells act as hidden glucose sponges in low-oxygen conditions, explaining why people living at high altitude have lower diabetes rates and pointing toward new treatments.
News Release Research (Publication) Diabetes Jain Lab